Fig. 3From: Neuroprotective effects of the PPARβ/δ antagonist GSK0660 in in vitro and in vivo Parkinson’s disease modelsWestern blotting representative images (C) and relative densitometric analysis for (S) mBDNF, pTRKB, pCREB, PI3K, pAKT and (B) cleaved Caspase9, cleaved Caspase3, cleaved PARP and pBCL2. (D) Live-cell IncuCyte Caspase-3/7 assay for control and treated cells (marked in green). Scale bar: 200 μmBack to article page